Abstract 2428
Background
Oropharyngeal squamous cell carcinoma (OPSCC) is divided into two entities: human papillomavirus-related (HPV-related) and HPV-unrelated. Although it is established that patients with HPV-related locally advanced OPSCC (LA-OPSCC) survive significantly better than those with HPV-unrelated LA-OPSCC when treated with chemoradiotherapy (CRT), CRT remains the standard treatment for HPV-related LA-OPSCC. Given the young generation being more prone to be affected by HPV-related OPSCC, patients suffer from severe late toxicity associated with CRT for a long time. The hypothesis has emerged that patients with HPV-related LA-OPCC could be well managed by de-intensified treatment, resulting in long-term less morbidity without compromising survival. A series of clinical trials are in progress to certify this hypothesis.
Methods
We did a single-arm, phase 2 trial, enrolling patients with newly diagnosed, biopsy-proven, stage III or IV (excluding T4 and/or N3) OPSCC, positive for both p16 and HPV DNA. Patients received intensity-modulated radiotherapy alone for 70 Gy in 35 fractions. The primary endpoint was response at 11th week after treatment, assessed on RECIST and PERCIST.
Results
Between August 2013 and November 2016, 39 patients were enrolled with a median age of 64 years (range, 49-83). The majority of patients (24, 62%) had ≥10 pack-years smoking history. 35 (90%) patients showed complete response on RECISIT and/or complete metabolic response on PERCIST. One patient had regional recurrence, and two had distant metastasis. The 2-year overall survival rate and progression-free survival rate was 96% and 91% (95% CI, 76-99 and 75-97), respectively. During treatment 10 patients had grade 3 adverse events, but no grade 4 events were reported. 7 patients had gastrostomy tube placed during treatment, but no patient was dependent on gastrostomy tube at 4 weeks after treatment.
Conclusions
Radiotherapy alone was associated with high disease control and an improved toxicity profile. Radiotherapy alone has the potential to replace CRT as the standard treatment for HPV-related LA-OPSCC.
Clinical trial identification
UMIN000008953; Release date: 09/20/2012.
Legal entity responsible for the study
Osaka University.
Funding
Has not received any funding.
Editorial Acknowledgement
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1159 - Molecular characterization and search for founding effects in Canarian families with Hereditary Breast and Ovarian Cancer Syndrome
Presenter: Elisenda Llabres Valenti
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3725 - Effect of the polymorphism rs2066844 of the NOD2 gene on colon cancer incidence in a high cardiovascular risk population. Modulation by gender
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3708 - Effect of the polymorphisms rs1476413, rs1801131, rs4846052 and rs6541003 of the MTHFR gene on prostate cancer in a high cardiovascular risk population
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5057 - Association of a genetic variant in cyclin-dependent kinase Inhibitor 2A gene with the increased risk of breast cancer
Presenter: Soodabeh Shahid Sales
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5970 - Investigating the role of HAT protein TIP60 in regulating functional dynamics of nuclear receptor PXR
Presenter: KARISHMA BAKSHI
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1360 - The role of downregulated SIRT3 expression in patients with hepatocellular carcinoma
Presenter: Hanhee Jo
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1634 - Prediction and Intervention of Colorectal Cancer Risk with Artificial Intelligent System
Presenter: Yang Ge
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
4921 - Measuring the Efficiency of Cancer Care in Europe
Presenter: Rikard Althin
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1235 - Circulating cell-free DNA isolated from plasma of mesenteric veins predicts prognosis in stage II colorectal cancer patients
Presenter: Chih-Yung Yang
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5169 - _lonality of uterine carcinosarcoma as a factor of clinical prognosis.
Presenter: Natalia Levitskaya
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract